About PneumRx
PneumRx is a Healthcare company based in Mountain View (United States) founded in 2004, and was acquired by BTG International in December 2014. Minimally invasive emphysema treatments using Nitinol lung coils are developed. PneumRx has raised $49.6 million across 3 funding rounds from investors including SVB, BTG International and Forbion. The company has 7 employees. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is PNEUMRX INC. Its competitors include Pulmonx, Spiration and Uptake Medical; 3 of its 3 listed competitors have raised funding.
Company details
PneumRx, Inc., a start-up medical device company, develops minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients. PneumRx Coils are small, shape-memory Nitinol implants, designed to gather and compress diseased tissue, re-tension the diseased airway network and mechanically increase the elastic recoil in the emphysematous lung. The shape-memory Nitinol Coils are delivered straight into sub-segmental airways through a therapeutic bronchoscope and recover their double-loop shape upon deployment. Part of the BTG group.
- Headquarters Mountain View, United States
- Employees 7
- Stage Acquired
- SectorsHealthcare
- Website pneumrx.com
- Social LinkedIn
- Acquired by BTG International (Dec 2014)
- Legal Name Pneumrx Inc
- Total Equity Funding$49.6M (USD)
in 3 rounds
- Latest Funding Round$11.88M (USD), Series C
Dec 2010
- InvestorsSVB
& 10 more
- Employee Count7
- Acquired byBTG International
(Dec 2014)
Funding Insights of PneumRx
PneumRx has successfully raised a total of $49.6M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $11.88 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.6M
- Total Rounds 3
- Last Round Series C β $11.88M
- First Round $10.73M
(Jun 2005)
- Investors Count 10
All 3 funding rounds of PneumRx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2010 | $11.88M | Series C | β | Forbion, Endeavour Vision | |
| Mar 2007 | $27M | Series B | β | Adams Street Partners, Telegraph Hill Partners | |
| Jun 2005 | $10.73M | Series A | β | β | β |
11 investors in total: 11 institutional.
Investors in PneumRx
PneumRx has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, BTG International and Forbion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on lifescience and healthcare sectors | forbion.com | Naarden, Netherlands | ||
Endeavour Vision is focused on transformative healthcare technology investments. | endeavourvision.com | Geneva, Switzerland | ||
Private markets investment management with strategies in equity, credit, and secondary investments. | adamsstreetpartners.com | |||
Venture capital firm focused on life science, medical device and healthcare companies | thpartners.net | San Francisco, United States | ||
Venture capital firm focused on healthcare companies | altapartners.com | Jackson, United States | ||
| spraypartners.com | ||||
Venture debt and equity financing is offered to US startups. | leaderventures.com | Palo Alto, United States | ||
| sagevp.com | ||||
Limited information is provided about KBL Healthcare Ventures. | kblhealthcare.com | |||
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States |
Investor details for PneumRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PneumRx
4 dated milestones of PneumRx across 10 years, from founding to its latest funding, stage changes and deals.
- Founded PneumRx is founded.
- Funding First funding round of $10.7M.
- Funding Latest funding round, Series C, of $11.9M.
- Exit Acquired by BTG International.
Competitors of PneumRx
PneumRx has 3 listed competitors in our database, 3 of them funded. They include Pulmonx, Spiration and Uptake Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pulmonx.com | 1998 | Redwood, United States | $280.91M | 198 | Developer of smart devices for treating pulmonary diseases | |
| spiration.com | 1999 | Redmond, United States | $73.9M | 74 | IntraBronchial Valve to treat lung disease | |
| uptakemedical.com | 2005 | Tustin, United States | $71.68M | Targeted vapor therapy is developed for endoscopic lung volume reduction. |
Detailed competitors of PneumRx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as PneumRx (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pneumrx
Complete news archive for PneumRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PneumRx
PneumRx was founded in 2004 and raised its 1st funding round 1 year after it was founded.
PneumRx is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
PneumRx is a funded company, having raised a total of $49.6M across 3 funding rounds to date. The company's 1st funding round was a Series A of $10.73M, raised on Jun 2005.
PneumRx has 7 employees.
PneumRx, Inc., a start-up medical device company, develops minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients. PneumRx Coils are small, shape-memory Nitinol implants, designed to gather and compress diseased tissue, re-tension the diseased airway network and mechanically increase the elastic recoil in the emphysematous lung. The shape-memory Nitinol Coils are delivered straight into sub-segmental airways through a therapeutic bronchoscope and recover their double-loop shape upon deployment. Part of the BTG group.
PneumRx's top competitors include Pulmonx, Spiration and Uptake Medical.
PneumRx has 11 investors. Key investors include SVB, BTG International, Forbion, Endeavour Vision, and Adams Street Partners.
PneumRx operates through Pneumrx Inc.
Yes. PneumRx was acquired by BTG International in December 2014.

